| |
About Novel |
Founded in December of 2006 by industry veteran, Dr. Veerappan Subramanian, Novel Laboratories, Inc. is a full-service pharmaceutical company that develops, manufactures, markets and distributes difficult to develop, technology-driven specialty generics for the US and European markets. With its core competencies in generics, Novel has also filed for multiple new products with the FDA and is anxiously awaiting approval.
The Company grows the majority of its products in-house in addition to partnering with pharmaceuticals worldwide to synergize development, manufacturing, and marketing capabilities. |
|
| |
News
|
October 8, 2010, Somerset, NJ |
| Novel receives tentative approval for the generic version of Salix Pharmaceuticals, OsmoPrep®. This first-to-file product is currently in litigation and does not have a determined launch date. |
June 15, 2010, Somerset, NJ |
| Novel and Salix Pharmaceuticals arrive at settlement with respect to Novel's generic OsmoPrep® product. The parties have agreed to an early entry date for Novel's generic product in 2011. Also, Novel is to contract manufacture brand products for Salix Pharmaceuticals.
|
May 26, 2010, Somerset, NJ |
| Novel inks exclusive marketing deal with Perrigo for the pending approval of the generic version of halfLYTELY®. |
| |
May 15, 2010, Somerset, NJ |
| Novel and Salix Pharmaceuticals settle pending litigation with respect to Novel's generic MoviPrep® product. The parties have agreed to an early date for Novel's generic product in 2011. Also, Novel is to contract manufacture some brand products for Salix Pharmaceuticals. |
| Read more >> |
|
